SOX2 and head and neck squamous cell carcinoma: It was demonstrated that TGF-β1 treatment enriches the properties of HNSCC CSC by enhancing sphere formation and increasing self-renewal and stemness-associated gene expression (Oct4 and Sox2) of primary HNSCC CSC.